KP Tissue Inc (KPT) Upgraded to “Buy” at TD Securities
KP Tissue Inc (TSE:KPT) was upgraded by analysts at TD Securities from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage currently has a C$16.00 target price on the stock. TD Securities’ price target would suggest a potential upside of 12.12% from the company’s previous close.
Separately, Scotiabank dropped their target price on KP Tissue from C$18.50 to C$18.00 and set an “outperform” rating on the stock in a research report on Friday, May 5th.
Shares of KP Tissue (TSE:KPT) traded up 1.12% during midday trading on Thursday, reaching $14.43. The company had a trading volume of 7,990 shares. KP Tissue has a 12-month low of $12.33 and a 12-month high of $16.34. The firm’s market capitalization is $132.05 million. The company has a 50 day moving average of $14.20 and a 200 day moving average of $15.10.
KP Tissue Company Profile
KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.
Receive News & Ratings for KP Tissue Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue Inc and related companies with MarketBeat.com's FREE daily email newsletter.